BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 27221314)

  • 1. Influence of different types of contact hypersensitivity on imiquimod-induced psoriasis-like inflammation in mice.
    Bai S; Zhang Z; Hou S; Liu X
    Mol Med Rep; 2016 Jul; 14(1):671-80. PubMed ID: 27221314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects of agonistic anti-4-1BB antibody on the development of imiquimod-induced psoriasis-like dermatitis in mice.
    Yoo JK; Choo YK; Kwak DH; Lee JM; Lim CY; Lee JH; Park MY; Kim CH
    Immunol Lett; 2016 Oct; 178():131-9. PubMed ID: 27592361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-glycoside of Tripterygium wilfordii Hook. f. ameliorates imiquimod-induced skin lesions through a STAT3-dependent mechanism involving the inhibition of Th17-mediated inflammatory responses.
    Zhao J; Di T; Wang Y; Liu X; Liang D; Zhang G; Li P
    Int J Mol Med; 2016 Sep; 38(3):747-57. PubMed ID: 27431437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Topical Application of Betamethasone on Imiquimod-induced Psoriasis-like Skin Inflammation in Mice.
    Mori H; Arita K; Yamaguchi T; Hirai M; Kurebayashi Y
    Kobe J Med Sci; 2016 Sep; 62(4):E79-E88. PubMed ID: 28239073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of γ-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation.
    Ma L; Xue H; Qi R; Wang Y; Yuan L
    J Transl Med; 2018 Mar; 16(1):59. PubMed ID: 29523162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paeonol ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice by inhibiting the maturation and activation of dendritic cells.
    Meng Y; Wang M; Xie X; Di T; Zhao J; Lin Y; Xu X; Li N; Zhai Y; Wang Y; Li P
    Int J Mol Med; 2017 May; 39(5):1101-1110. PubMed ID: 28339016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis.
    van der Fits L; Mourits S; Voerman JS; Kant M; Boon L; Laman JD; Cornelissen F; Mus AM; Florencia E; Prens EP; Lubberts E
    J Immunol; 2009 May; 182(9):5836-45. PubMed ID: 19380832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression of IL-27 in moderate-to-severe psoriasis and its anti-inflammation role in imiquimod-induced psoriasis-like mouse model.
    Chen W; Gong Y; Zhang X; Tong Y; Wang X; Fei C; Xu H; Yu Q; Wang Y; Shi Y
    J Dermatol Sci; 2017 Feb; 85(2):115-123. PubMed ID: 27939414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous n-3 polyunsaturated fatty acids protect against imiquimod-induced psoriasis-like inflammation via the IL-17/IL-23 axis.
    Qin S; Wen J; Bai XC; Chen TY; Zheng RC; Zhou GB; Ma J; Feng JY; Zhong BL; Li YM
    Mol Med Rep; 2014 Jun; 9(6):2097-104. PubMed ID: 24718773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipocalin-2 exacerbates psoriasiform skin inflammation by augmenting T-helper 17 response.
    Hau CS; Kanda N; Tada Y; Shibata S; Uozaki H; Fukusato T; Sato S; Watanabe S
    J Dermatol; 2016 Jul; 43(7):785-94. PubMed ID: 26702876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azithromycin impairs TLR7 signaling in dendritic cells and improves the severity of imiquimod-induced psoriasis-like skin inflammation in mice.
    Huang SW; Chen YJ; Wang ST; Ho LW; Kao JK; Narita M; Takahashi M; Wu CY; Cheng HY; Shieh JJ
    J Dermatol Sci; 2016 Oct; 84(1):59-70. PubMed ID: 27449383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paeoniflorin inhibits imiquimod-induced psoriasis in mice by regulating Th17 cell response and cytokine secretion.
    Zhao J; Di T; Wang Y; Wang Y; Liu X; Liang D; Li P
    Eur J Pharmacol; 2016 Feb; 772():131-43. PubMed ID: 26738780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcipotriol and betamethasone dipropionate exhibit different immunomodulatory effects on imiquimod-induced murine psoriasiform dermatitis.
    Takeoka S; Shimizu T; Kamata M; Hau CS; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y
    J Dermatol; 2020 Feb; 47(2):155-162. PubMed ID: 31762070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of pathogenesis of imiquimod-induced skin inflammation in the mouse: a role for interferon-alpha in dendritic cell activation by imiquimod.
    Ueyama A; Yamamoto M; Tsujii K; Furue Y; Imura C; Shichijo M; Yasui K
    J Dermatol; 2014 Feb; 41(2):135-43. PubMed ID: 24387343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteopontin deficiency affects imiquimod-induced psoriasis-like murine skin inflammation and lymphocyte distribution in skin, draining lymph nodes and spleen.
    Frenzel DF; Borkner L; Scheurmann J; Singh K; Scharffetter-Kochanek K; Weiss JM
    Exp Dermatol; 2015 Apr; 24(4):305-7. PubMed ID: 25655893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Losartan ointment attenuates imiquimod-induced psoriasis-like inflammation.
    Shokrian Zeini M; Haddadi NS; Shayan M; Shokrian Zeini M; Kazemi K; Solaimanian S; Abdollahifar MA; Hedayatyanfard K; Dehpour AR
    Int Immunopharmacol; 2021 Nov; 100():108160. PubMed ID: 34583123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astilbin inhibits Th17 cell differentiation and ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice via Jak3/Stat3 signaling pathway.
    Di TT; Ruan ZT; Zhao JX; Wang Y; Liu X; Wang Y; Li P
    Int Immunopharmacol; 2016 Mar; 32():32-38. PubMed ID: 26784569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
    Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
    Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and profiling of immunomodulatory genes in resident mesenchymal stem cells reflect the Th1-Th17/Th2 imbalance of psoriasis.
    Campanati A; Orciani M; Consales V; Lazzarini R; Ganzetti G; Di Benedetto G; Di Primio R; Offidani A
    Arch Dermatol Res; 2014 Dec; 306(10):915-20. PubMed ID: 25160906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-27 activates Th1-mediated responses in imiquimod-induced psoriasis-like skin lesions.
    Shibata S; Tada Y; Asano Y; Yanaba K; Sugaya M; Kadono T; Kanda N; Watanabe S; Sato S
    J Invest Dermatol; 2013 Feb; 133(2):479-88. PubMed ID: 22951728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.